I ntroduction
Obesity is rapidly becoming a worldwide epidemic, leading to numerous medical conditions such as type 2 diabetes and cardiovascular disease. The development of obesity is marked by both an increase in adipocyte size and number as a consequence of differentiation of the stem cells or preadipocytes into mature adipocytes (for review see Gesta et al., 2007 ) . Spontaneous differentiation of embryonic stem (ES) cells into adipocytes in culture is a rare event; thus, for ES cells to commit toward the adipocyte lineage, it is necessary to pretreat cells with retinoic acid (RA), a ligand of the nuclear receptor retinoid X receptor (RXR), during the fi rst phase of differentiation ( Dani et al., 1997 ) . RXR in response to RA heterodimerizes with peroxisome proliferator -activated receptor (PPAR), resulting in activation of genes involved in terminal differentiation and lipid metabolism ( Gregoire et al., 1998 ) . PPAR ␥ 2, CCAAT enhancer -binding protein ␣ (C/EBP ␣ ), and aP2 are crucial for the development of adipose cells ( Rosen et al., 2000 ) . The process of adipogenesis may also be infl uenced by different extrinsic factor and intracellular signaling pathways ( Rosen and MacDougald, 2006 ), yet very little is known about the role of Ca 2+ homeostasis in adipogenesis. Increased Ca 2+ levels lead to inhibition of adipocyte differentiation, which is accompanied by the decrease or, in some cases, the loss of PPAR ␥ 2, C/EBP ␣ , and aP2 expression ( Jensen et al., 2004 ; Serlachius and Andersson, 2004 ; Zhang et al., 2007 ) . Thapsigargin, an inhibitor of the sarco/ER Ca 2+ -ATPase, inhibits adipocyte differentiation in 3T3-L1 preadipocytes ( Ntambi and Takova, 1996 ; Shi et al., 2000 ) , suggesting a role for ER stores and ER Ca 2+ -binding proteins in the modulation of adipogenesis.
Calreticulin is a major Ca
2+
-buffering protein in the lumen of the ER, which also acts as a molecular chaperone and modulator of gene expression ( Bedard et al., 2005 ) . The two major functions of calreticulin, chaperoning and Ca 2+ buffering, are confi ned to specifi c protein domains. The N+P domain of calreticulin forms a folding module, and the acidic C-terminal C domain binds and buffers Ca 2+ with high capacity ( Baksh and Michalak, 1991 ; Nakamura et al., 2001 ) . Calreticulin defi ciency is embryonic lethal , and calreticulin-defi cient cells have a reduced capacity for Ca 2+ storage C alreticulin, an endoplasmic reticulum (ER) resident protein, affects many critical cellular functions, including protein folding and calcium homeostasis. Using embryonic stem cells and 3T3-L1 preadipocytes, we show that calreticulin modulates adipogenesis. We fi nd that calreticulin-defi cient cells show increased potency for adipogenesis when compared with wild-type or calreticulin-overexpressing cells. In the highly adipogenic crt Ϫ / Ϫ cells, the ER lumenal calcium concentration was reduced. Increasing the ER lumenal calcium concentration led to a decrease in adipogenesis. In calreticulin-defi cient cells, the calmodulin -Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) pathway was up-regulated, and inhibition of CaMKII reduced adipogenesis. Calreticulin inhibits adipogenesis via a negative feedback mechanism whereby the expression of calreticulin is initially up-regulated by peroxisome proliferator -activated receptor ␥ (PPAR ␥ ). This abundance of calreticulin subsequently negatively regulates the expression of PPAR ␥ , lipoprotein lipase, CCAAT enhancer -binding protein ␣ , and aP2. Thus, calreticulin appears to function as a Ca
-dependent molecular switch that regulates commitment to adipocyte differentiation by preventing the expression and transcriptional activation of critical proadipogenic transcription factors. Fig. 1 A shows that the adipogenic potential of ES cells, as measured by oil red O staining at differentiation day 20 (D20), was ‫ف‬ 30-fold higher in the absence of calreticulin. The number of adipocyte colonies in calreticulin-deficient embryoid bodies (EBs) was approximately ninefold higher than that in the calreticulin-containing EBs at D20 ( Fig. 1 B ) . This was irrespective of whether the calreticulin gene was removed by homologous recombination (G45 crt Ϫ / Ϫ cells) or by Cre within the ER and impaired agonist-stimulated Ca 2+ release from ER stores, whereas cells overexpressing calreticulin have higher levels of lumenal ER Ca 2+ and a larger pool of releasable Ca 2+ ). Calreticulin ' s impact on protein folding and Ca 2+ homeostasis have been implicated in several signaling pathways ( Bedard et al., 2005 ) , thus affecting gene expression and, consequently, the behavior of individual cells and cell communities. In this study, we show that calreticulin may act as a Ca 2+ -dependent molecular switch that negatively regulates commitment to adipocyte differentiation by preventing the expression and transcriptional activation of critical proadipogenic transcription factors. Figure 1 . Adipogenesis increases in calreticulin-defi cient EBs. Oil red O is a lysochrome used for staining triglycerides and some lipoproteins, thus being useful in visualizing the degree of adipogenesis. (A) At D20, calreticulin-defi cient ES cells (G45 crt Ϫ / Ϫ and L7 crt Ϫ / Ϫ ) stained more extensively with oil red O than WT cells (P < 0.01; n = 6) and made more adipocyte colonies (P < 0.01; n = 5) (B). (C) The ES cells lacking calreticulin (G45 crt Ϫ / Ϫ and L7 crt Ϫ / Ϫ ) showed an increase in expression of PPAR ␥ 2, C/EBP ␣ (by Western blotting), and aP2 (by PCR) compared with the WT or L7 cells. Relative protein levels were determined by normalizing the calreticulin, PPAR ␥ 2, and C/EBP ␣ to GAPDH, and aP2 mRNA levels were normalized with the housekeeping gene L32. (D) Quantitative analysis of the relative expression of adipogenic markers at D20 (P < 0.01; n = 6). (E) Oil red O staining and Western blot analysis with anticalreticulin (CRT) antibodies of 3T3-L1 preadipocytes and 3T3-L1 cells overexpressing calreticulin (3T3-L1 + CRT). 3T3-L1 cell fi broblasts overexpressing calreticulin showed reduced oil red O staining. (F) RT-PCR showing that adipogenic marker expression decreased in 3T3-L1 + CRT cells overexpressing calreticulin compared with control 3T3-L1 cells. Error bars represent SD.
Calreticulin inhibits commitment to adipocyte differentiation
calreticulin-defi cient and calreticulin-containing cells, which makes it diffi cult to visualize all of them when equally loaded. Modulation of the expression of calreticulin also impacted adipogenesis of 3T3-L1 preadipocytes, a commonly used model for adipogenesis ( Otto and Lane, 2005 ) . Increased expression of calreticulin in 3T3-L1 preadipocytes inhibited their adipogenesis, as indicated by oil red O staining ( Fig. 1 E ) . In agreement with ES cell results, molecular markers of adipogenesis (lipoprotein lipase, aP2, PPAR ␥ 2, C/EBP ␣ , and C/EBP ␤ ) were all down-regulated in 3T3-L1 cells overexpressing calreticulin ( Fig. 1 F ) .
Upon induction of adipogenesis with RA, the abundance of calreticulin increased dramatically in the WT ES cells ( Fig. 2 A ) , whereas the abundance of PPAR ␥ 2 and C/EBP ␣ remained persistently low ( Fig. 2, B and C ) . In contrast, in calreticulin-defi cient (G45 crt Ϫ / Ϫ ) cells after induction of adipogenesis with RA, PPAR ␥ 2 and C/EBP ␣ levels steadily increased over 20 d of differentiation ( Fig. 2, B and C ) . Similar to the WT ES cells, the 3T3-L1 preadipocytes and 3T3-L1 cells overexpressing calreticulin showed an increase in calreticulin abundance and reduced adipogenic potential upon RA treatment ( Fig. 2, D and E ) . We concluded that the increased expression of calreticulin plays a negative regulatory role during adipogenesis.
recombinase -mediated excision (L7 crt Ϫ / Ϫ cells; Fig. S1 A, available at http://www.jcb.org/cgi/content/full/jcb.200712078/DC1). Adipogenesis in ES cells was RA and insulin dependent and required an initial 3-d exposure to RA followed by insulin treatment (unpublished data). Microscopically, by Nile red staining, lipid droplets in the wild-type (WT) adipocytes were indistinguishable from those in calreticulin-defi cient cells (Fig. S1 B) , indicating that the gross morphology of lipid stores was not affected in the absence of calreticulin. Nile red is a red-emitting fl uorescent lysochrome that can be used as a fl uorescent alternative to oil red O lipid visualization . Fig. S2 shows the nucleotide sequence of the calreticulin promoter.
Next, we examined the expression of both early (C/EBP ␣ and PPAR ␥ 2) and late (aP2) adipogenic markers. The abundance of PPAR ␥ 2 and C/EBP ␣ adipogenesis markers was markedly increased at D20 in G45 crt Ϫ / Ϫ and L7 crt Ϫ / Ϫ cells compared with WT ( Fig. 1, C and D ) . The aP2 mRNA levels were undetectable in extracts from the WT and L7 cells, whereas they were high at D20 in extracts from calreticulindefi cient cells ( Fig. 1, C and D ) . It should be stressed that in Fig. 1 C as well as in subsequent fi gures, adipogenic markers in calreticulin-containing cells are barely discernible. This is caused by a large disparity in the markers ' abundance between or L7 crt Fig. 3, A and B ) . In contrast, after treatment with ionomycin, there was no detectable oil red O -positive adipocytes derived from WT and L7 cells, whereas differentiation of both calreticulin-defi cient cell lines (G45 crt Ϫ / Ϫ and L7 crt Ϫ / Ϫ ) produced an extremely low number of oil red O -positive cells ( Fig. 3, A and B ) .
In agreement with oil red O staining results, BAPTA-AM treatment signifi cantly increased the abundance of all three adipogenic markers in adipocytes derived from WT and L7 cells containing calreticulin but did not have a signifi cant effect on adipocytes derived from calreticulin-defi cient (G45 crt Ϫ / Ϫ and L7 crt Ϫ / Ϫ ) ES cells ( Fig. 3, C and D ) . In the presence of ionomycin, the levels of PPAR ␥ 2, C/EBP ␣ , and aP2 remained nearly undetectable in extracts from WT and L7 cells ( Fig. 3, C and E ) . However, ionomycin signifi cantly decreased the abundance of PPAR ␥ 2, C/EBP ␣ , and aP2 levels in extracts from calreticulin-defi cient cell lines (G45 crt Ϫ / Ϫ and L7 crt
) at D20 ( Fig. 3, C and E ).
Changes in the intracellular Ca

2+ concentration affect adipogenesis
One important function of calreticulin is modulation of Ca 2+ homeostasis Bedard et al., 2005 ) . Thus, we next examined whether calreticulin-dependent changes in Ca 2+ homeostasis might be responsible for modulation of adipogenesis. We used BAPTA-AM, a membrane-permeable Ca 2+ chelator ( Tsien, 1980 ) , to lower cytosolic Ca 2+ concentration ([Ca 2+ ] Cyto ) as well as ionomycin, a Ca 2+ ionophore ( Bergling et al., 1998 ) Ϫ / Ϫ cells (P < 0.01; n = 6) and was comparable to that in WT cell levels (P > 0.05). BAPTA-AM treatment increased adipogenic marker expression in all cell lines ( n = 6). (E) Adipogenic marker expression was higher in the N+P domain -expressing G45 crt Ϫ / Ϫ cells than in the WT ES cells (P < 0.01; n = 6) and was similar to that in G45 crt Ϫ / Ϫ cell levels (P > 0.05). Ionomycin treatment reduced adipogenic marker expression in all cell lines ( n = 6). ] ER than the control 3T3-L1 cells ( n = 3). Error bars represent SD. 
Modulation of adipogenesis by functional modules of calreticulin
Calreticulin has two structural and functional domains ; one responsible for chaperoning, and another for Ca 2+ buffering ( Fig. 4 A ) . To determine which of calreticulin ' s functions (domains) may be involved in the modulation of adipogenesis, two ES cell lines expressing single functional modules of calreticulin in calreticulin-defi cient ES cells (G45 crt Ϫ / Ϫ ) were created and tested for adipogenic potential. Because the C domain of calreticulin cannot be stably maintained, it was fused to the P domain of calreticulin ).
Expression of the domains was tracked using anti-HA antibodies ( Fig. 4 A ) . Fig. 4 B shows that reexpression of the P+C domain in calreticulin-defi cient cells inhibited adipogenesis ( Fig. 4, B and D ) . Overexpression of the P+C domain in 3T3-L1 preadipocytes also resulted in reduced adipogenesis ( Fig. 4 C ) . Treatment of the P+C domain -expressing crt Ϫ / Ϫ ES cells with BAPTA-AM restored their adipogenic potential ( Fig. 4, B and D ) . In contrast, expression of the N+P domain in crt Ϫ / Ϫ ES cells had no significant effect on their ability to differentiate into adipocytes, and they maintained a phenotype identical to calreticulin-defi cient calreticulin or the P+C domains in the 3T3-L1 preadipocytes also resulted in increased [Ca 2+ ] ER and [Ca 2+ ] Tot compared with control 3T3-L1 cells ( Fig. 4 H ) The results so far suggested that calreticulin plays a modulatory role during adipogenesis. We next wanted to determine whether there was a functional relationship between calreticulin and the PPAR ␥ transcriptional complex. Upon RAdependent induction of adipogenesis, RXR and PPAR ␥ form a transcriptionally active complex. The calreticulin promoter contains two PPAR ␥ -binding sites termed peroxisome proliferator responsive elements (PPREs); one is found at Ϫ 1,944 bp (designated PPRE1), and the other is found at Ϫ 590 bp (designated PPRE2; Fig. 5 A ) , suggesting that the PPAR ␥ transcription factor may regulate the calreticulin gene. To test this, NIH3T3 fi broblasts were cotransfected with PPAR ␥ expression vector and RXR ␣ expression vector (pLC0, pLC1, pLC2, pLC0mt1, and pLC0mt2) or luciferase reporter gene vectors (pCL2 and pCL3; Fig. 5 A ) under control of the calreticulin promoter. pSV ␤ -galactosidase was used as an internal control. In the pLC0 vector, luciferase was controlled by 2.1 kb of the calreticulin promoter containing both PPRE sites ( ( Fig. 4 B ) . This was further supported by BATPA-AM and ionomycin experiments ( Fig. 4 ) . The total cellular Ca 2+ content was then calculated based on the cell-associated radioactivity and on the specifi c activity of Ca 2+ in the culture medium. We used thapsigargin, an inhibitor of sarco/ER Ca 2+ -ATPase, to measure the amount of Ca 2+ associated with ER-exchangeable intracellular Ca 2+ stores in either ES ( Fig. 4 F ) or 3T3-L1 ( Fig. 4 H ) cells. To assess the residual amount of Ca 2+ contained within thapsigargin-insensitive lumenal Ca 2+ stores, we used the Ca 2+ ionophore ionomycin ( Fig. 4, F ] Tot , respectively, compared with the crt Ϫ / Ϫ ES cells ( Fig. 4 F ) .
To provide yet another measure of ER-releasable Ca 2+ , we measured thapsigargin-induced Ca 2+ discharge from the ER versus cytosolic [Ca 2+ ] using the Ca 2+ -sensitive fl uorescent dye fura-2-AM under conditions preventing dye sequestration into the ER ( Mery et al., 1996 ) . Fig. 4 increased adipogenesis), PPAR ␥ 2 was distinctly nuclear ( Fig. 6 A ) . However, in the WT ES cells, PPAR ␥ 2 was barely detectable and appeared cytosolic ( Fig. 6 B ) . Given that the WT ES cells show reduced adipogenesis and, thus, only sparse adipocyte colonies, Fig. 6 B represents a region of low adipogenic potential that predominates in WT outgrowths. Localization of C/EBP ␣ was also investigated in the ES cells, and it showed an essentially identical pattern to that observed for PPAR ␥ 2 (unpublished data).
Calmodulin/CaMKII, CREB, and calcineurin during adipogenesis
Calmodulin -Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) and cAMP response element binding (CREB pathways affect adipogenesis ( Wang et al., 1997 ; Reusch et al., 2000 ) . Western blot analysis with anti-Thr286 -phosphorylated CaMKII, anticalmodulin, and anti-Ser133 -phosphorylated CREB antibodies showed that their expression was higher in calreticulin-defi cient G45 crt Ϫ / Ϫ and L7 crt Ϫ / Ϫ cells than in WT and L7 cells at the end of the 20 d of differentiation ( Fig. 7, A and B ) . These results indicate that CaMKII and CREB play a positive role during adipogenesis of crt Ϫ / Ϫ cells and that they are up-regulated in the absence of calreticulin.
To elucidate the role of the CaMKII pathway, we used specifi c inhibitors of CaMKII, KN-62 and KN-93 ( Hidaka and Kobayashi, 1994 ) . Inhibition of CaMKII in G45 crt Ϫ / Ϫ and L7 crt Ϫ / Ϫ cells with either KN-62 or KN-93 decreased adipogenesis ( Fig. 7, C and D ) . Inhibition of CaMKII also resulted in the decreased expression of PPAR ␥ 2, C/EBP ␣ , and aP2 in all cell lines, with the most dramatic effects in calreticulindefi cient cells ( Fig. 7, E and F ) . KN-92, an inactive analogue of KN-93, did not alter oil red O staining ( Fig. 7, C and D ) or adipogenic marker expression in either crt Ϫ / Ϫ or calreticulincontaining ES cells ( Fig. 7, E and F ) . These data suggest that the calmodulin -CaMKII pathway plays an important role during adipogenesis from ES cells.
Calcineurin is a negative regulator of adipogenesis ( Neal and Clipstone, 2002 ; Kennell and MacDougald, 2005 ) and is known to affect calcineurin activity ( Guo et al., 2002 ; Lynch et al., 2005 ) . On D20, calcineurin activity was signifi cantly higher in the WT ES cells than in the calreticulin-defi cient cells ( Fig. 7 G ) . In the 3T3-L1 preadipocytes, inhibition of calcineurin with cyclosporin-A promoted adipogenesis ( Fig. 7, H and I ) , whereas constitutive expression of activated calcineurin decreased adipogenesis ( Fig. 7, H and I ). These data give support for the promoterless control plasmids showed no detectable luciferase activity (unpublished data). This fi nding indicates that PPAR ␥ activates transcription of the calreticulin gene.
To identify the PPAR ␥ -binding site on the calreticulin promoter, we performed reporter gene assay with calreticulin promoter deletions and mutations ( Fig. 5, B and C ) . Deletion of PPRE1 and PPRE2 sites (pLC2 vector) completely abolished PPAR ␥ -dependent activation of the calreticulin promoter ( Fig. 5 B ) . Deletion of PPRE site 2 at Ϫ 1,944 bp ( Fig. 5 A ) or mutation of PPRE site 1 or 2 ( Fig. 5 A ) had no effect on PPAR ␥ activation of the promoter ( Fig. 5, B and C ) . Thus, upon induction of adipogenesis with RA, RXR and PPAR ␥ form a complex, which binds PPRE sites 1 and 2 on the calreticulin promoter and transcriptionally activates the calreticulin gene.
To further elucidate a physical interaction between the calreticulin promoter and PPAR ␥ , an electrophoretic mobility shift assay (EMSA) was performed ( Fig. 5 C ) . Synthetic oligodeoxynucleotides corresponding to PPRE sites 1 and 2 were used along with a positive control probe, an ideal PPAR site. Fig. 5 C shows that the PPAR ␥ -RXR ␣ complex bound to PPRE1 and PPRE2. This DNA -protein interaction was only observed in the presence of RXR ␣ , indicating that PPAR ␥ is only functional once complexed with RXR ␣ ( Fig. 5 C ) . The specifi city of the PPRE and PPAR ␥ -RXR ␣ binding was confi rmed by reduced signal intensity after the addition of 30-fold excess of cold probe ( Fig. 5 C ) . The lesser intensity in PPRE1 and PPRE2 complexes ( Fig. 5 C , lanes 4 and 6) when compared with complexes containing the ideal PPRE site ( Fig. 5 C , lanes 1, 3, and  10 ) is likely the result of the different nucleotide sequences of these probes. Specifi city of the binding was further confi rmed by supershift EMSA and mutation of both PPRE sites ( Fig. 5 D ) . Chromatin immunoprecipitation (ChIP) was also performed to determine whether there was a direct interaction between the calreticulin promoter and PPAR ␥ . ChIP analysis indicated that PPAR ␥ bound to both PPRE sites 1 and 2 on the calreticulin promoter ( Fig. 5 E ) . We concluded that the PPAR ␥ -RXR ␣ complex binds to calreticulin PPRE1 and PPRE2 sites and activates the calreticulin gene.
PPAR ␥ 2, along with C/EBP ␣ , directly affect gene transcription in the nucleus ( Rosen, 2005 ; Rosen and MacDougald, 2006 ) . Given that PPAR ␥ 2 is both necessary and suffi cient for adipogenesis ( Rosen et al., 2000 ) , we determined its spatial expression during adipogenesis in our ES cell system ( Fig. 6 ) . On D20 of differentiation in the crt Ϫ / Ϫ ES cells (which exhibit role of calcineurin in adipogenesis of both ES cells and 3T3-L1 preadipocytes. The present fi ndings are consistent with earlier studies relating activation of calcineurin to the presence of calreticulin ( Lynch and Michalak, 2003 ; Lynch et al., 2005 ) .
Discussion
In this study, we show that calreticulin affects adipocyte differentiation from either ES cells or 3T3-L1 preadipocytes. The absence of calreticulin sways ES cell differentiation toward the adipocyte lineage. ] at later stages of differentiation (i.e., D7 or D9) did not alter the respective adipogenic potential of ES cells (unpublished data). This is consistent with what has been done to elicit calciumdependent effects during ES cell differentiation by Li et al. (2002) , who used 100 nm ionomycin at D4, and Grey et al. (2005) , who used 100 nm ionomycin at D6. Interestingly, Li et al. (2002) showed that ionomycin could be used at concentrations of 10 -1,000 nM at days 4 -7 with the same effects. Moreover, as calreticulin levels were increasing during the fi rst 3 d of differentiation, PPAR ␥ 2 and C/EBP ␣ levels were decreasing, implying that the effects of calreticulin fall within the commitment and/or initial stages of adipogenesis. We conclude that calreticulin may act as a Ca 2+ -dependent molecular switch that negatively regulates commitment to adipocyte differentiation by down-regulating the expression and transcriptional activation of critical proadipogenic transcription factors.
Ca
2+ -handling module of calreticulin inhibits adipogenesis
An important fi nding of this study is that calreticulin, at least in part, exerts its effects on adipogenesis via its role as a modulator of Ca 2+ homeostasis. Ca 2+ has previously been shown to affect adipogenesis of 3T3-L1 preadipocytes ( Shi et al., 2000 ; Jensen et al., 2004 ) . For example, 3T3-L1 cells exposed to elevated external Ca 2+ levels accumulated little or no cytoplasmic lipids and showed the diminished expression of PPAR ␥ 2, C/EBP ␣ , and aP2 ( Jensen et al., 2004 ) . Increasing cytoplasmic Ca 2+ levels by thapsigargin also inhibited early stages of adipogenesis ( Shi et al., 2000 ) , all pointing out the importance of Ca 2+ on adipogenesis. Indeed, we show here that an increase in intracellular Ca 2+ concentration leads to a decrease in adipocyte differentiation. -buffering P+C domain, adipogenesis was halted, whereas expression of the N+P domain had no effect on the progression of adipogenesis.
Our fi ndings that calreticulin affects the commitment to adipocyte differentiation are in line with reports that calreticulin-dependent Ca 2+ signaling also affects several aspects of the differentiation of cardiomyocytes Grey et al., 2005; Puceat and Jaconi, 2005 ) and human myeloid cells ( Clark et al., 2002 ) . Interestingly, diminished intracellular Ca 2+ stores attenuate cardiomyogenesis but promote adipogenesis and differentiation of myeloid cells. Combined, these fi ndings imply that calreticulin and ER Ca 2+ must play important roles in a variety of differentiation pathways. Moreover, our data regarding timing of the [Ca 2+ ] manipulations indicate that in adipogenesis, as in cardiomyogenesis , there is a calreticulinregulated calcium-sensitive step referred to as a checkpoint by Li et al. (2002) .
CaMKII and calcineurin activities are crucial for adipogenesis
Both CaMKII and calcineurin are Ca 2+ dependent and have been implicated in affecting adipogenesis ( Wang et al., 1997 ; Neal and Clipstone, 2002 ; Kennell and MacDougald, 2005 ) . The CaMKII pathway is involved in C/EBP ␣ regulation and, thus, indirectly in PPAR regulation. CaMKII activates CREB, which, in turn, activates C/EBP ␣ ( Fajas et al., 2002 ; Wang et al., 2003 ; Zhang et al., 2004 ) . CREB plays a role in adipogenesis, and, indeed, expression of dominant-negative CREB blocks adipogenesis ( Reusch et al., 2000 ; Klemm et al., 2001 ; Reusch and Klemm, 2002 ; Fox et al., 2006 ; Vankoningsloo et al., 2006 ) . CaMKII is also involved in the activation of PPAR ␥ ( Paez- Pereda et al., 2005 ; Park et al., 2007 ) , indicating that the CaMKII pathway may be critical during adipogenesis. Once C/EBP ␣ is expressed, PPAR ␥ and C/EBP ␣ regulate each other, thereby promoting adipogenesis ( Rosen, 2005 ) . Here, we show that increased levels of threonine-phosphorylated CaMKII in calreticulin-defi cient cells correlate with their increased adipogenesis, and inhibition of CaMKII attenuates adipogenesis in these cells. In calreticulindefi cient cells, in addition to increased CaMKII activity, calmodulin and CREB are also up-regulated, thus explaining the elevated adipogenesis in these cells.
Given that [Ca 2+ ] ER is lower in calreticulin-defi cient cells, the question arises as to how CaMKII activity could be increased in these cells. In calreticulin-defi cient cells, the level of tyrosine phosphorylation, including that of c-Src , is higher than in WT cells ( Fadel et al., 1999 ( Fadel et al., , 2001 Szabo et al., 2007 ) . Activated c-Src phosphorylates calmodulin on tyrosine 99, thereby increasing the affi nity of calmodulin for CaMKII ( Abdel-Ghany et al., 1990 ; Benaim and Villalobo, 2002 ) . This phosphorylation event is inhibited by high Ca 2+ pression of calreticulin is tightly regulated during adipogenesis, and any modifi cation of this expression infl uences adipogenesis such that aberrant calreticulin expression may lead to a variety of cellular pathologies, including obesity and diabetes.
Materials and methods
Cell culture and adipocyte differentiation G45 crt Ϫ / Ϫ ES cells and the WT ES cell line (CGR8) were derived from J1 129/Sv mice. To generate the L7 ES cell line, J1 129/Sv ES cells were electroporated with a targeting vector containing the calreticulin gene with the loxP site inserted in introns 1 and 2 (Fig. S1 A) and maintained on mitomycin C -treated G-418 -resistant mouse embryonic fi broblast feeder cells . Recombinant clones were selected with 0.2 mg/ml G418 and 2 mM gancyclovir. Several hundred colonies were picked after 10 d in selection medium and expanded. The L7 clone was selected based on Southern blot analysis and Western blot analysis with anticalreticulin antibodies . Cre recombinase with additional mutant estrogen receptor ligand-binding domains (Cre-ER and MerCreMer) was used to excise exons 2 -4 from the calreticulin gene (Fig. S1 A) . In brief, L7 ES cells were stably transfected with Cre recombinase mutant expression vector pANMerCreMER (a gift from J.D. Molkentin, University of Cincinnati, Cincinnati, OH) to generate the L7-Cre cell line. To generate L7 crt
, 10 μ M 4-hydroxytamoxifen was added to promote nuclear translocation and consequently activation of Cre recombinase. L7 crt Ϫ / Ϫ contained a truncated and silenced calreticulin gene with interrupted reading frame and no expression of the protein ( Fig. 1 C ) . Calreticulin-defi cient ES (G45 crt Ϫ / Ϫ ) cell lines expressing N+P and P+C domains of the protein were also created and designated G45 crt Ϫ / Ϫ N+P and G45 crt Ϫ / Ϫ P+C. Adipocyte differentiation was performed by hanging drop method. In brief, 1,000 ES cells in 20-μ l drops were placed on the lids of tissue culture dishes for 2 d. The differentiation medium contained high glucose DME (Multicell; Wisent) supplemented with 15% FBS (Multicell; Wisent), sodium pyruvate, L-glutamine, minimal essential medium nonessential amino acids, and ␤ -mercaptoethanol. After 2 d, the aggregated ES cells formed EBs, which were fl oated in differentiation medium supplemented with 10 Ϫ 7 M RA for an additional 3 d. The EBs were then plated onto tissue culture dishes coated with 0.1% gelatin (in PBS) in differentiation medium supplemented with 1 μ g/ml insulin and 2 nM triiodothyronine. The differentiation medium was changed every 2 d for the duration of differentiation (15 d). The EBs were then collected for Western blot analysis, RNA isolation, or staining with oil red O.
Mouse embryonic fibroblasts were isolated from calreticulindefi cient (K42) and WT embryos (K41) as previously described ( Nakamura et al., 2000 ) . The 3T3-L1 preadipocyte cells were cultured in DME supplemented with 10% bovine growth serum at 37 ° C. For adipocyte differentiation, 2-d postconfl uent cells were cultured for 2 d in differentiation medium containing 1 μ M dexamethasone, 0.5 mM methylisobutylxanthine, 5 μ g/ml insulin, and 0.5 μ M rosiglitazone (Cayman Chemical). Afterward, the 2-d insulin (5 μ g/ml) and 0.5 μ M rosiglitazone were added. At day 9 of differentiation, the cells were harvested for Western blot analysis, RNA isolation, or staining with oil red O.
Plasmid DNA and transfections pSG5-rRxR ␣ and pSG5-mPPAR ␥ 2 were gifts from R. Rachubinski (University of Alberta, Edmonton, Alberta, Canada). Plasmid DNA was purifi ed using Mega plasmid preparation and columns (QIAGEN) as recommended by the manufacturer. Expression vectors encoding the HA-tagged N+P domain (pcDNA3.1_Zeo-CRTNPd-1) and P+C domain (pcDNA3.1_Zeo-CRTPCd-3) of calreticulin were previously described . ES cells were electroporated with 30 μ g/cuvette of pcDNA3.1_Zeo-CRTNPd-1 or pcDNA3.1_Zeo-CRTPCd-3 expression vector by electroporation (1, 500 V/cm; 25 IxF) , and Zeocin (30 μ g/ml)-resistant clones were isolated. Expression of the recombinant N+P and P+C domains was monitored with anti-HA antibodies .
3T3-L1 cells were stably transfected with pcDNA3.1-CRT (encoding HA-tagged full-length calreticulin), pcDNA3.1_Zeo-CRTNPd-1, or pcDNA3.1_Zeo-CRTPCd-3 using Lipofectamine reagent (Invitrogen) according to the manufacturer ' s instructions. 3T3-L1 clones expressing fulllength calreticulin or calreticulin domains were selected with 50 μ g/ml Zeocin. Expression of recombinant proteins was monitored with anti-HA antibodies ).
concentration ( Fukami et al., 1986 ) . Tyrosine-phosphorylated calmodulin effectively activates CaMKII ( Corti et al., 1999 ) . In addition, after initial activation, CaMKII becomes autophosphorylated, remaining active even though its activators are removed ( Meyer et al., 1992 ) . Therefore, CaMKII may remain active and promote adipogenesis in calreticulin-defi cient cells even under reduced intracellular Ca 2+ concentration. We have found that endogenous calcineurin activity was signifi cantly higher in calreticulin-expressing cells that have reduced adipogenic potential compared with the calreticulindefi cient cells that are highly adipogenic. This is in agreement with previous studies on calcineurin-dependent inhibition of adipogenesis ( Neal and Clipstone, 2002 ; Kennell and MacDougald, 2005 ) . Thus, we propose that although the calcineurin pathway inhibits adipogenesis, the Ca 2+ -independent CaMKII pathway might be responsible for the promotion of adipogenesis in the absence of calreticulin observed here.
Calreticulin modulates PPAR ␥ activity through a negative feedback mechanism PPAR ␥ 2 and C/EBP ␣ are crucial transcription factors during adipogenesis ( Rosen, 2005 ) ; however, although PPAR ␥ 2 is necessary for adipogenesis to take place ( Rosen et al., 2000 ) , C/EBP has a more accessory role during this process ( Rosen et al., 2002 ) . We showed here that PPAR ␥ 2 and C/EBP ␣ are downregulated in cells overexpressing calreticulin. Therefore, calreticulin may act as a transcriptional regulator of PPAR, whereby it inhibits the binding of PPAR/RXR to PPRE in the promoter region of the target genes, thus inhibiting transcription activation by peroxisome proliferators and by fatty acids ( Burns et al., 1994 ; Dedhar et al., 1994 ; Winrow et al., 1995 ) . Here, we show that the initial process that precedes the effects of calreticulin on the activity of the PPAR ␥ -RXR complex involves PPAR ␥ transcriptional activation of the calreticulin gene. PPAR ␥ is a potent transcriptional activator of the calreticulin gene as a result of its direct interaction with the calreticulin promoter. Thus, PPAR ␥ can up-regulate calreticulin, and, conversely, calreticulin can inhibit its activity. We also found an inverse relationship between calreticulin and PPAR ␥ 2 expression upon induction of adipogenesis with RA. RA induces the expression of calreticulin but reduces the expression of PPAR ␥ 2. This supports the notion of a hierarchical process in which transcriptional activation of the calreticulin gene by PPAR ␥ is the early event followed by calreticulin modulation of PPAR ␥ transcriptional activity. These data provide evidence for a previously unrecognized negative feedback loop whereby PPAR ␥ regulates the expression of calreticulin, and calreticulin modulates PPAR ␥ 2 activity and expression. This is likely one important mechanism whereby calreticulin and ER Ca 2+ homeostasis regulate adipogenesis. In conclusion, for the fi rst time, we show an essential role for organellar Ca 2+ in adipogenic regulation. The presence of calreticulin inhibits adipogenesis through its effects on Ca 2+ homeostasis, causing the indirect regulation of crucial pathways affecting adipogenesis, such as the calcineurin and CaMKII pathways. Although the CaMKII pathway is important for adipogenic differentiation, the calcineurin pathway may be involved in other choices of fate of ES cells. Finally, we show that the ex-GTCCTCGATG-3 Ј ; for C/EBP ␣ , reverse primer 5 Ј -CGCAAGAGCCGA-GATAAAGC-3 Ј and forward primer 5 Ј -GCGGTCATTGTCACTGGTCA-3 Ј ; for aP2, reverse primer 5 Ј -CATCAGCGTAAATGGGGATT-3 Ј and forward primer 5 Ј -TCGACTTTCCATCCCACTTC-3 Ј ; and for L32, reverse primer 5 Ј -CATGGCTGCCCTTCGGCCTC-3 Ј and forward primer 5 Ј -CATTCTCTTC-GCTGCGTAGCC-3 Ј . PCR products were separated in 1.5% agarose gel. The mRNA levels were normalized using L32 as the housekeeping gene, and relative mRNA levels were quantifi ed using ImageJ software.
Oil red O staining
Before staining with oil red O, cells were washed twice with PBS, fi xed with 10% formaldehyde for 15 min at room temperature, and washed twice with distilled water and once with 70% isopropanol. Next, cells were stained for 1 h at room temperature with fi ltered oil red O at a ratio of 60% oil red O stock solution (0.5% wt/vol in isopropanol) to 40% distilled water. The cells were washed twice with distilled water, twice with PBS, and examined under a light microscope. An invertoscope (Diaphot; Nikon) equipped with a 10/0.25 DL dry plan Apochromatic objective (Nikon) was used for imaging at room temperature. A camera (Coolpix 4500; Nikon) was used for image acquisition. For quantitative analysis, oil red O was extracted with 5 ml isopropanol for 2 min, and optical density of each sample was determined at 540 nm.
EMSA
Full-length RXR ␣ and PPAR ␥ and luciferase control proteins were synthesized using a coupled transcription and translation reticulocyte system (Promega; Guo et al., 2001 ) . Synthetic oligodeoxynucleotides corresponding to PPAR site 1 (PPRE1; 5 Ј -AGTGTGG AGGTCAGAGGACA CCGGCTC-3 Ј ) and PPAR site 2 (PPRE2; 5 Ј -TCCTGGC TGGCCCTTGACCT TATCCTG-3 Ј ) in the calreticulin promoter were used. An ideal PPRE oligodeoxynucleotide sequence, 5 Ј -CAAAACT AGGTCAAAGGTCA AGGCATC-3 Ј , was used as a positive control. Underlined residues correspond to the PPAR-binding site. Deoxyoligonucleotides were labeled with ␥ -[ 32 P]ATP (GE Healthcare) using T4 polynucleotide kinase. EMSA was performed as described previously ( Guo et al., 2001 ) . For supershift analysis, anti-HA tag antibodies were used.
ChIP assay
ChIP assay was performed as described previously ( Lynch et al., 2005 ) . In brief, NIH-3T3 cells were transiently transfected with HA-PPAR ␥ and cross-linked in 1% formaldehyde at room temperature for 20 min. Cells were then lysed with the Extract-N-Amp kit (Sigma-Aldrich) according to the manufacturer ' s instructions. Chromatin was sheared by sonication followed by centrifugation for 10 min. Supernatants were precleared with protein A -Sepharose beads for 1 h at 4 ° C. Immunoprecipitation was performed with mouse anti-HA antibodies at 4 ° C overnight. DNA was purifi ed and analyzed by PCR using the following primers: PPRE site 1, forward primer 5 Ј -TGTGTCTGAAGACAGCTACAGTG-3 Ј and reverse primer 5 Ј -GCAGCAGGAGAAAAGAAGAGAG-3 Ј ; PPRE site 2, forward primer 5 Ј -CTCTATGGCCTGAACAACTGTG -3 Ј and reverse primer 5 Ј -TGGTCAGAGGGAAGAAGTAAGG -3 Ј Calcineurin activity assay Calcineurin activity assay was performed as previously described ( Fruman et al., 1992) . In brief, a peptide corresponding to the regulatory domain of protein kinase A (Sigma-Aldrich) was used as the substrate in an in vitro dephosphorylation assay (RII peptide). 1.0 × 10 6 cells were lysed in 50 ml hypotonic lysis buffer containing 50 mM Tris, pH 7.5, 0.1 mM EGTA, 1 mM EDTA, 250 mM DTT, and protease inhibitors. 20 ml of lysate was added to 5 mM ␥ -[ 32 P] -labeled RII peptide. The reaction was performed for 20 min at 30 ° C in the presence of 0.5 mM okadaic acid with a total reaction volume of 60 ml. The released phosphate reported the activity of calcineurin and was expressed in picomoles of phosphate released per milligrams of total protein.
Immunofl uorescence and Nile red staining
Cells on coverslips were fi xed in 3.7% formaldehyde in PBS for 10 min. After washing (three times for 5 min) in PBS, the cells were permeabilized with 0.1% Triton X-100 in buffer containing 100 mM Pipes, pH 6.9, 1 mM EGTA, and 4% (wt/vol) polyethylene glycol 8000 for 2 min, washed three times for 5 min in PBS, and incubated with goat polyclonal anti-PPAR ␥ 2 antibody (diluted 1:50 in PBS; Santa Cruz Biotechnology, Inc.) for 30 min at room temperature. After washing three times for 5 min in PBS, the cells were incubated with the secondary antibody for 30 min at room temperature. The secondary antibody was FITC-conjugated donkey anti -goat IgG(H+L) diluted 1:50 in PBS. The cells were then incubated with 0.2 mM Reporter gene assay 3T3-NIH cells were cotransfected with reporter plasmid containing the calreticulin promoter, deletion of the calreticulin promoter, or the calreticulin promoter with mutations of PPRE1 or PPRE2 (pLC0, pLC1, pLC2, pLC0mt1, and pLC0mt2), PPAR ␥ , and RXR ␣ expression vectors. pLC1 and pLC2 plasmids encode the luciferase reporter gene under the control of 1.7-kb and 0.4-kb calreticulin promoters, respectively ( Waser et al., 1997 ) . pLC0 encoded the luciferase reporter gene under control of the 2.1-kb calreticulin promoter ( Waser et al., 1997 ) . To generate pLC0mt1 and pLC0mt2 plasmids, sitedirected mutagenesis of PPRE1 and PPRE2 of the calreticulin promoter, respectively, was performed using the QuikChange Site-Directed Mutagenesis kit (Stratagene). Specifi cally, PPRE1 (AGGTCAGAGGACA) was mutated to AGGctcGAGGAtc, whereas PPRE2 (TGGCCCTTGACCT) was mutated to ccGggCTgctCCc (lowercase letters are mutated nucleotides). After 48 h, cells were harvested in a lysis buffer containing 100 mM Tris, pH 7.8, 0.5% NP-40, and 0.5 mM DTT. Luciferase and ␤ -galactosidase activity were measured as described previously ( Waser et al., 1997 ) .
Inhibitor studies
At the fl oating stage (days 3 -5 of differentiation), EBs were incubated with KN-62 CaMK inhibitor or its inactive analogue (KN-93; Hidaka and Kobayashi, 1994 ) at concentrations of 10 μ M for 2 h during the 3 d of EB fl otation stage. The optimal inhibitory concentrations of KN-62 and KN-93 were determined to be in the range of 10 to 15 μ M. Under these conditions, the drugs had no effect on cell survival/proliferation. For inhibition of calcineurin, 3T3-L1 preadipocytes were incubated with 1 μ g/ml cyclosporin-A. The cells were then allowed to differentiate for an additional 15 d and were harvested for Western blot analysis, RNA isolation, or staining with oil red O. ] measurements using the Ca 2+ -sensitive fl uorescent dye fura-2-AM were performed as previously described in detail by Mery et al. (1996) . The ionomycin and BAPTA-AM treatment regimen was performed as previously described by Li et al. (2002) and Grey et al. (2005) with the following modifi cations: to obtain the optimal functional output, three consecutive pulse treatments were used for either ionomycin or BAPTA-AM. To chelate cytoplasmic Ca 2+ , fl oating EBs were incubated with 50 nM BAPTA-AM for 30 min at days 3 -5 of differentiation. To increase cytoplasmic Ca 2+ , the EBs were incubated for 2 h with 500 nM ionomycin in the same manner. Exposure to ionomycin or BAPTA-AM exerts a signifi cant change even after 1 d of treatment, but optimal results were obtained with three pulses of treatment on three consecutive days of differentiation. The cells were then allowed to differentiate on gelatinized (0.01%) tissue culture dishes for 15 d, after which they were collected for Western blot analysis, RNA isolation, or staining with oil red O.
Ca
SDS-PAGE and Western blot analysis
Cells were harvested in a lysis buffer containing 50 mM Tris-HCl, pH 8.0, 120 mM NaCl, and 0.5% NP-40. Protein concentration was determined by the method of Bradford ( Bradford, 1976 ) . Protein samples (10 μ g per lane) were separated by SDS-PAGE and transferred to nitrocellulose membrane . Western blot analysis was performed with the following antibodies: anti-PPAR ␥ 2 (Sigma-Aldrich and Santa Cruz Biotechnology, Inc.) at 1:1,000 dilution; anticalreticulin ( Opas et al., 1991 ) at 1:300 dilution; anti-C/EBP ␣ (Santa Cruz Biotechnology, Inc.) at 1:1,000 dilution; anti -glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Labfrontiers) at 1:5,000 dilution; anti-CaMKII (Affi nity BioReagents) at 1:1,000 dilution; antiphospho-CaMKII Thr286 (Invitrogen) at 1:500 dilution; anticalmodulin (Affi nity BioReagents) at 1:1000 dilution; and anti-CREB pSer133 (Sigma-Aldrich) at 1:1,000 dilution. All secondary antibodies were horseradish peroxidase conjugated (Jackson Immunochemicals) and were used at 1:100,000 dilution. Immunoreactive bands were detected with a chemiluminescence ECL Western blotting system (GE Healthcare). Western blots were normalized by using anti-GAPDH antibodies. Relative mRNA levels were normalized to the housekeeping gene L32. Bands were quantifi ed using ImageJ software (National Institutes of Health).
RNA preparation and RT-PCR analysis
Total RNA was isolated from cells grown in 10-cm tissue culture dishes using TRIzol reagent (Invitrogen) according to the manufacturer ' s instructions. 1 μ g RNA was used for synthesis of cDNA followed by RT-PCR using Superscript II (Invitrogen) according to the manufacturer ' s protocol. The following primers were used for PCR analysis: for PPAR ␥ , forward primer 5 Ј -ATCAAGTTCAAACATATCACC-3 Ј and reverse primer 5 Ј -TTGTCTTGGAT-
